Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis
β Scribed by Earl D. Silverman; Ronald M. Laxer; Mark Greenwald; Erwin Gelfand; Abraham Shore; Leonard D. Stein; Chaim M. Roifman
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 574 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Patients who had active and severe rheumatoid arthritis (RA) were treated with human placentaβeluted gamma globulins (PEGG) composed of purified IgG eluted from trophoblastic cells. A control group of RA patients received retroplacental gamma globulins with no clinical effects. Seven of
## Abstract Gold therapy for 6 months was shown to be efficacious in reducing the severity of articular manifestations in 32 (63%) of 51 juvenile rheumatoid arthritis patients reviewed retrospectively. Similarly, reductions in the total number of involved joints were seen in 25 (49%) patients. Pati
Nineteen selected patients with severe, mostly systemic onset, juvenile rheumatoid arthritis were treated with methotrexate (MTX) for an average of 10.5 months. Twelve patients showed statistically significant improvement, as measured by the number of affected, swollen, tender, and functionally impa